Health Condition 1: null- Generalized lichen planus
Conditions
Interventions
None listed
Sponsors
Department of Dermatology
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patient diagnosed with generalized lichen planus. 2.Baseline investigations including complete blood count, liver and renal function tests, chest x ray, hepatitis B surface antigen and hepatitis C antibody
Exclusion criteria
Exclusion criteria: 1. Pregnant or lactating women 2. Hemoglobin 2 times the upper reference range, active tuberculosis, hepatitis B surface antigen and hepatitis C antibody positive status.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Outcome of this study was low dose oral methotrexate is effective& is a reasonably safe option for generalized LP. There was better tolerance by patients with low recurrence rate than subcutaneous low molecular weight heparin.outcome of this study was low dose oral methotrexate is effective& is a reasonably safe option for generalized LP. There was better tolerance by patients with low recurrence rate than subcutaneous low molecular weight heparin.Timepoint: 4 years | — |
Secondary
| Measure | Time frame |
|---|---|
| Outcome of this study was low dose oral methotrexate is effective& is a reasonably safe option for generalized LP. There was better tolerance by patients with low recurrence rate than subcutaneous low molecular weight heparin.outcome of this study was low dose oral methotrexate is effective& is a reasonably safe option for generalized LP. There was better tolerance by patients with low recurrence rate than subcutaneous low molecular weight heparin.Timepoint: 4 years | — |
Countries
India
Contacts
Public ContactDr Snehal Lunge
JNMC, KLE university
Outcome results
None listed